tirzepatide synergy nash Will the GLP-1 giants kill the smid-caps? Tough week for some smid-cap NASH stocks 2/6/24 $LLY announced 📢 • positive Ph2 MASH (AKA NASH) data ⇨ MASH resolution (74%) of Los resultados del ensayo SYNERGY-NASH

Individual responses to GLP-1 therapy depend on baseline metabolic status, kidney function, and genetic predispositions in fluid-regulation pathways

Purpose-built for physicians Semaglutide cuts risk for worsening heart failure, CV death among adults with HFpEF Key takeaways: Semaglutide lowered the risk for worsening heart failure or CV death by 31% compared with placebo

Type 2 diabetes treatment often demands in-person assessments, lab work, and meticulous monitoring which isn't fully compatible with telehealth alone

A 40-year-old starting a Retatrutide protocol has roughly 15% less natural collagen production than they did at 25

If constipation develops on your weight loss therapy, psyllium can help, but introduce it cautiously and always with plenty of water